Green LifeScience Co

Green LifeScience Co EBIT/Assets

The Operating Income to Assets Ratio (EBIT/Assets) of Green LifeScience Co (114450.KQ) as of Oct 21, 2026 is 0.37 %. In the previous year, Operating Income to Assets Ratio (EBIT/Assets) was 0.84 % — a change of -55.57% (lower).

EBIT/Assets

0.37 %

YoY

-55.57%

Last updated:

Operating Income to Assets Ratio (EBIT/Assets) of Green LifeScience Co is 2025 0.37 % . Operating Income to Assets Ratio (EBIT/Assets) of Green LifeScience Co was 2024 0.84 % . It decreases by -55.57% lower compared to the previous year.

The Green LifeScience Co EBIT/Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT/Assets
Date
EBIT/Assets
Jan 1, 2018
-2.81 KRW
Jan 1, 2019
0.82 KRW
Jan 1, 2020
-2.69 KRW
Jan 1, 2021
-6.46 KRW
Jan 1, 2022
-6.34 KRW
Jan 1, 2023
-38.19 KRW
Jan 1, 2024
0.84 KRW
Jan 1, 2025
0.37 KRW
The Green LifeScience Co EBIT/Assets history
YEAREBIT/AssetsYoY
0.37 %-55.57%
0.84 %-102.19%
-38.19 %+502.37%
-6.34 %-1.83%
-6.46 %+139.66%
-2.69 %-427.74%
0.82 %-129.22%
-2.81 %-185.27%
3.30 %-49.47%
6.53 %-20.94%
8.26 %-399.86%
-2.75 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Green LifeScience Co Stock analysis

What does Green LifeScience Co do? Green LifeScience Co Ltd produces and sells pharmaceutical and agricultural raw materials and intermediates, including AMZ for crop protection, TAZD as a herbicide intermediate, D003M and T003M for artificial marble additives, and PM04 as a pharmaceutical intermediate. The company distributes its products domestically and to international markets such as Japan, the United States, and Europe, where customers purchase these materials for agricultural and pharmaceutical applications. The firm also offers antibiotics as part of its product portfolio, targeting both domestic and overseas buyers seeking specialized chemical compounds. Green LifeScience Co Ltd generates revenue through the sale of its chemical products to customers in the agricultural and pharmaceutical sectors, with key markets including Japan, the United States, and European countries. The company’s product line caters to the needs of manufacturers requiring raw materials for crop protection, herbicides, and pharmaceutical production. Its domestic and international distribution channels support consistent sales across these segments, leveraging established relationships with buyers in the chemical supply chain. The company's offerings include specific chemical compounds like AMZ, TAZD, D003M, T003M, and PM04, which are sold to customers who integrate them into larger production processes. These products are used in the creation of crop protection materials, herbicides, artificial marble, and pharmaceuticals, serving both local and global markets. Antibiotics are also part of the sales mix, contributing to the firm’s revenue from chemical intermediates and raw materials. Green LifeScience Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Green LifeScience Co stock

Operating Income to Assets Ratio (EBIT/Assets) of Green LifeScience Co is 0.37 % in 2025.

Operating Income to Assets Ratio (EBIT/Assets) of Green LifeScience Co changed from 0.84 % to 0.37 %, representing a -55.57% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Income to Assets Ratio (EBIT/Assets) Green LifeScience Co since 2006 – with annual values, charts, and detailed analysis.

EBIT/Assets measures operating profitability relative to total assets, providing an unlevered view of asset efficiency that is comparable across capital structures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Income to Assets Ratio (EBIT/Assets)'s Green LifeScience Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Income to Assets Ratio (EBIT/Assets)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Income to Assets Ratio (EBIT/Assets).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Green LifeScience Co

All Key Metrics — Green LifeScience Co